PIK3CA and neoplasm: C2C12 myoblast cells expressing exogenous MYOD1L122R exhibited tumor formation in in vivo xenograft models in comparison to the parental cell line which does not form tumors in mice, however, when the MYOD1L122R mutation was combined with an activating mutation in PIK3CA, a dramatic increase in tumor size was observed.